scispace - formally typeset
O

Oliver A. Cornely

Researcher at University of Cologne

Publications -  638
Citations -  35879

Oliver A. Cornely is an academic researcher from University of Cologne. The author has contributed to research in topics: Medicine & Voriconazole. The author has an hindex of 81, co-authored 541 publications receiving 27426 citations. Previous affiliations of Oliver A. Cornely include Sheba Medical Center & University of Bonn.

Papers
More filters
Journal ArticleDOI

1,3-β-d-Glucan contamination of common antimicrobials

TL;DR: A majority of the available antimicrobial substances contained BDG, potentially limiting the utility of BDG testing in the context of prior exposure to these drugs and efforts to reduce contamination should be considered.
Journal ArticleDOI

EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis.

TL;DR: The EQUAL Aspergillosis Score 2018 aggregates and weighs the components and provides a tool to support antifungal stewardship and to quantify guideline adherence.
Journal ArticleDOI

Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci.

TL;DR: The data suggest that ex vivo chemosensitivity testing evaluated by the Ci could serve as a powerful tool for assay‐directed therapy strategies in AML.
Journal ArticleDOI

A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

Massimo Sartelli, +241 more
- 01 Nov 2017 - 
TL;DR: This declaration, signed by an interdisciplinary task force of 234 experts from 83 different countries with different backgrounds, highlights the threat posed by antimicrobial resistance and the need for appropriate use of antibiotic agents and antifungal agents in hospitals worldwide especially focusing on surgical infections.